VOICED : Primera dosis de vacuna anticovid de Pfizer es eficaz en un 85% tras 2-4 semanas

VOICED : Primera dosis de vacuna anticovid de Pfizer es eficaz en un 85% tras 2-4 semanas

Assessment

Interactive Video

Biology, Science, Health

9th - 10th Grade

Practice Problem

Hard

Created by

Wayground Content

FREE Resource

The Pfizer-BioNTech COVID-19 vaccine shows 85% efficacy after the first dose, according to a study conducted at Israel's Sheva Hospital and published in The Lancet. The study involved 9,109 healthcare workers, revealing that the vaccine's efficacy is 47% between days 1 and 14, and 85% between days 15 and 28 post-vaccination. The study also highlights the importance of the second dose to achieve 95% efficacy. Israel's vaccination campaign began on December 19, with a significant portion of the population receiving at least one dose, facilitated by an agreement with Pfizer to share biomedical data.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the efficacy of the first dose of the Pfizer-BioNTech vaccine after two to four weeks?

85%

95%

100%

47%

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How many healthcare workers participated in the study conducted at Sheva Hospital?

7,500

10,000

8,000

9,109

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What percentage of the study participants had received the first dose of the vaccine?

60%

90%

80%

70%

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What was the efficacy of the vaccine between days 15 and 28 after the first dose?

100%

85%

47%

95%

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What percentage of Israel's population had received at least one dose of the vaccine by the time of the study?

32%

47%

60%

50%

Access all questions and much more by creating a free account

Create resources

Host any resource

Get auto-graded reports

Google

Continue with Google

Email

Continue with Email

Classlink

Continue with Classlink

Clever

Continue with Clever

or continue with

Microsoft

Microsoft

Apple

Apple

Others

Others

Already have an account?